<i>CCNE1</i> and <i>PLK1</i> Mediate Resistance to Palbociclib in HR+/HER2− Metastatic Breast Cancer
Ángel Guerrero‐Zotano(Fundación Instituto Valenciano de Oncología), Miguel Martín(Hospital General Universitario Gregorio Marañón)
Cited by 54
Related Papers
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
|Breast Cancer Research and Treatment|2009|82